➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKinsey
McKesson
Mallinckrodt
Johnson and Johnson

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

CLOBAZAM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for clobazam and what is the scope of patent protection?

Clobazam is the generic ingredient in three branded drugs marketed by Aquestive Therap, Amneal Pharms Llc, Bionpharma Inc, Hetero Labs Ltd Iii, Hikma, Lannett Co Inc, Lupin Ltd, Mylan, Taro, Teva Pharms Usa, Upsher Smith Labs, Vistapharm, Lundbeck Pharms Llc, Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Breckenridge, Micro Labs, Piramal Hlthcare Uk, and Zydus Pharms, and is included in twenty-nine NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Clobazam has one hundred and sixty-one patent family members in eighteen countries.

There are ten drug master file entries for clobazam. Twenty suppliers are listed for this compound.

Drug Prices for CLOBAZAM

See drug prices for CLOBAZAM

Recent Clinical Trials for CLOBAZAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Besson MariePhase 2
Elizabeth ThielePhase 3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.Phase 3

See all CLOBAZAM clinical trials

Pharmacology for CLOBAZAM

US Patents and Regulatory Information for CLOBAZAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd CLOBAZAM clobazam TABLET;ORAL 210545-002 Dec 14, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-001 Oct 21, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare CLOBAZAM clobazam TABLET;ORAL 212398-002 May 23, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
McKesson
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.